Cup Breakout with Multi-Signal Confirmation on a Fundamentally Strong Pharma Stock

Technical Structure (Based on the Chart) 1. Elliott Wave Perspective The stock has completed a large corrective Wave (II) in the form of a rounded Cup structure, visible over multiple months. Price is now attempting a Wave (III) initiation, confirmed by a breakout attempt above the cup rim near ₹1,510–1,520. The gradual rise on the right side of the cup indicates accumulation, not speculative spikes — a healthy setup for impulsive upside waves. If Wave (III) unfolds fully, measured move projections align with ₹2,100–2,200, consistent with the marked target zone on the chart. 2. MACD Behaviour (Momentum Confirmation) During the bottoming phase, price made lower lows, while momentum (MACD) showed higher lows → bullish divergence. Recent MACD crossover into positive territory supports the idea that momentum has shifted from corrective to impulsive. This divergence often precedes strong multi-month advances, especially on weekly timeframes. 3. AVWAP as Dynamic Support The stock has reclaimed and is holding above AVWAP from the prior swing high, which now acts as strong demand support. Every pullback toward this zone has been bought into, suggesting institutions are defending their average cost. As long as price stays above AVWAP, the trend bias remains bullish. Fundamental Strength (Why the Setup is Trustworthy) The company operates in a defensive yet high-growth pharmaceutical segment, offering stability during market volatility. High ROCE reflects efficient capital deployment and operational strength. Consistent profit growth over recent years indicates scalability rather than one-off earnings. Balance sheet quality supports long-term compounding, aligning well with the Wave (III) expansion thesis.